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IDPpi: Protein-Protein Interaction 
Analyses of Human Intrinsically 
Disordered Proteins
Vladimir Perovic1, Neven Sumonja1, Lindsey A. Marsh2, Sandro Radovanovic3, 
Milan Vukicevic3, Stefan G. E. Roberts2 & Nevena Veljkovic1
Intrinsically disordered proteins (IDPs) are characterized by the lack of a fixed tertiary structure and 
are involved in the regulation of key biological processes via binding to multiple protein partners. 
IDPs are malleable, adapting to structurally different partners, and this flexibility stems from features 
encoded in the primary structure. The assumption that universal sequence information will facilitate 
coverage of the sparse zones of the human interactome motivated us to explore the possibility of 
predicting protein-protein interactions (PPIs) that involve IDPs based on sequence characteristics. We 
developed a method that relies on features of the interacting and non-interacting protein pairs and 
utilizes machine learning to classify and predict IDP PPIs. Consideration of both sequence determinants 
specific for conformational organizations and the multiplicity of IDP interactions in the training phase 
ensured a reliable approach that is superior to current state-of-the-art methods. By applying a strict 
evaluation procedure, we confirm that our method predicts interactions of the IDP of interest even on 
the proteome-scale. This service is provided as a web tool to expedite the discovery of new interactions 
and IDP functions with enhanced efficiency.
Protein–protein interactions (PPIs) underlie many processes essential to living organisms and hence, are funda-
mental to the functional annotation of proteins. So far, we have been acquiring genomic information much faster 
than knowledge and understanding of protein interactions. Low-throughput experimental studies that reveal 
PPIs are not only expensive and labour-intensive, but also suffer from bias in favour of well-studied proteins. 
Under the circumstances, in silico prediction methods are a valuable complement that can prioritize candidates 
for rigorous experimental testing or eliminate those less likely to interact. To this end, computational approaches 
that utilize machine learning classifiers and rely on available PPI data predict uncovered segments of the interac-
tome at an accuracy similar to those of high-throughput techniques and appear to be particularly useful for their 
comprehensiveness1–3. These methods operate on protein sequences converted into feature vectors, so they are 
universal and easily applicable, which is an advantage over computationally-intensive structure-based molecular 
docking methods. However, supervised machine learning algorithms for PPI predictions suffer from inherent 
limitations in foreseeing interactions of components that were unseen by the model during the training process. 
Several papers have reflected on sustainable estimates of PPI prediction performances and their ability to gener-
alize to physiological environments4,5.
Intrinsically disordered proteins (IDPs) represent a structural class of proteins that do not have well-defined 
tertiary structures in several regions or throughout the entire sequence6–8. This conformational plasticity is asso-
ciated with sequence compositional characteristics including low proportions of bulky hydrophobic amino acids 
and a high content of charged and hydrophilic residues9. The ability of a single IDP to bind to several structurally 
dissimilar partners, complemented with the ability of many different IDPs to bind to a single partner, results in 
exceptional binding promiscuity10. Coupled folding and binding, one inherent property of IDPs, is associated 
with their propensity to form low-affinity complexes which govern or maintain signalling processes11. Thus, many 
IDPs act as hubs in interaction networks and have central roles in the regulation of signalling pathways12. On the 
other hand, in fuzzy complexes, bound IDPs might remain fully or partially disordered13.
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IDPs habitually have multiple functions and underpin key cellular processes, including the regulation of 
transcription, translation and the cell cycle. In addition to regulatory roles, IDPs are key players in many other 
biological processes such as molecular recognition, binding of small molecules, and the organization of chro-
matin14–17. IDPs are the prevailing protein class associated with noncommunicable diseases18,19 and therefore, 
mapping the interactome of IDPs will lead to improved understanding of disease mechanisms and provide the 
platform for novel therapeutic approaches20,21. Thus, it is an important task of computational biology to provide 
model PPI networks of IDPs and to enable reliable predictions of candidate interactors. The flexible structure of 
IDPs imposes restrictions on the application of precise computational methods for modelling interactions based 
on docking. This is because they rely on putative binding modes according to favourable interaction energies and 
surface complementarities, thus requiring candidates with stable, well-defined, globular three-dimensional struc-
tures22,23. On the other hand, data-driven methods have no inherent barriers to respond to this task, but require 
methods to prevent bias in the training while carrying out a realistic estimation of performance.
In this study, we used compositional features to decode amino acid strings and implemented machine learning 
algorithms to predict binary interactions that involve IDPs. With a strict evaluation procedure and attention to 
potential setbacks intrinsic to data-based methods, we demonstrate that our classifier grasps key characteristics 
of PPIs and is capable of predicting interactions of an IDP of interest with significant efficiency.
Results and Discussion
Overview of the data sets. The database of protein disorder (DisProt) collects data on intrinsically dis-
ordered proteins and its current version holds information on 237 human entities24. Some of these proteins are 
entirely disordered, whereas others contain both disordered regions and globular domains. In this study, we 
utilized this dataset as a representative of human disordered proteins and the term IDP is used as a universal 
expression to denote an intrinsically disordered human protein. The interactome made of binary PPIs that involve 
at least one IDP from the DisProt was extracted from the Human Integrated Protein-Protein Interaction rEfer-
ence (HIPPIE) database25, a source specialized in human interactions, which combines information on PPIs with 
experimental annotation from ten primary repositories. The HIPPIE data are manually curated and associated 
with a quality scoring scheme that we used to eliminate less reliable data. As mentioned earlier, the complexity 
of the disorder-based interactomes is increased through the capacity of a single IDP to bind to multiple partners. 
Several studies have shown a correlation between the disorder of a protein and the number of its partners26–28. 
Indeed, according to the statistics of the version of HIPPIE that we used, the number of interactions per IDP is 
approximately 3.5 times higher than that of PPIs per ordered protein. Specifically, the average number of interac-
tions per IDP is 112.77, whereas the average number of interactions per ordered protein is 31.58 (Fig. 1).
In such an environment, the concern that hub proteins will dominate the PPI prediction algorithm is realis-
tic and reasonable. In order to preclude representational bias in the learning process, we performed a balanced 
sampling of negative PPIs. Thus, all sequences, components of protein pairs appeared evenly in the positive and 
negative parts of the training set. A common approach towards building a negative dataset is to sample protein 
pairs that are not known to interact. The number of false negatives in such collections is considered low because 
number of protein pairs significantly exceeds the number of recognized interactions. For the test sets, negatives 
were subsampled randomly as required for evaluation of the PPI prediction method at a population-level29,30.
As a first step in generating datasets we retrieved 24,994 interactions with at least one IDP included (Fig. 2). 
Of note, the number of interactions per IDP in our dataset is close to the average per disordered protein in the 
human proteome. The redundancy among the initial set of 7,557 interactors was reduced by removing sequences 
with identity levels higher than 40% by clustering analysis using the CD-HIT31. The remaining dataset encom-
passed 20,216 interactions involving 5,805 unique ordered sequences. Next, we removed interactions that were 
less reliable in experimental annotation. The remaining items are partitioned randomly into training and test sets 
for holdout validation. We repeated this 5 times ensuring that the test pairs share only one IDP component with 
the training set. The entire list of 5 training sets can be found as Supplementary Tables S1–5.
Figure 1. Number of interactors - density curves for the interactions in the HIPPIE database. IDPs density 
curve is represented by a red line and ordered proteins are denoted non-IDPs and their density curve is a blue 
line. The average number of interactions per IDP is 112.77; The average number of interactions per ordered 
protein is 31.58.
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It is estimated that at least 30% of the human proteome contains disordered regions and consequently the 
IDP dataset used in our study covers a tiny part of the human disordered proteome. Nevertheless, according 
to the number of known interactions it seems that the dataset used here contains well-explored IDPs that are 
functionally important. We anticipate that future upgrades of the DisProt and HIPPIE databases will significantly 
contribute to information on human IDPs and that these prospective improvements to datasets used for testing 
and training will positively influence the quality of the predictions.
Human Disorder PPI predictions. IDPs exhibit highly specific sequence composition32 across both the 
overall structure33 and binding domains34. In PPIs that involve IDPs the binding energy depends on residue 
composition, interface sizes, and flexibility of the interaction partners35. This motivated us to explore the use of 
residue composition in engineering features associated with the selection of binding partners. Two types of amino 
acid composition were employed in depicting full-length sequences. Firstly, the alphabetic series was transformed 
into feature vectors by means of the dipeptide composition which views every two consecutive amino acids as a 
single element and counts the frequency of all of dipeptide configurations. Second, we used pseudo amino acid 
composition (PAAC) and incorporated five amino acid propensity scales: the TOP-IDP scale which ranks resi-
dues by the their propensity to endorse order or disorder36, B-values which quantitates the flexibility parameters 
for each residue surrounded by two inflexible neighbours37, the FoldUnfold scale which represents the capacity of 
amino acid residues to form a sufficient number of contacts in a globular state38, the DisProt scale which is based 
on the statistical difference in the residue composition of ordered proteins and IDPs as in36 and the net charge 
scale39. The PAAC composition contains both a conventional amino acid composition and factors that incor-
porate sequence-order information via feature correlation functions40. Protein pairs were vectorized by a single 
sequence vectors concatenation and represented as 940-dimensional vectors.
In a previous study Park and Marcotte4 explored the consequences of the component-level overlap between 
the training and the test sets by distinguishing three types of test-pairs. They did this according to whether they 
share both, one or no sequence/s with the protein pairs in the training set. This approach demonstrated that 
each method achieved the best performances for the test sets that shared both components with the training 
and the worst for those that shared none. In the present study, which aimed to assess how our method executes 
on proteome-scale predictions, we performed evaluation experiments on test pairs which shared only the IDP 
component with a training dataset. Firstly, we used 10-fold cross-validation to select the best performing machine 
learning algorithm among Random Forests (RF), Gradient Boosting Machine (GBM), Support Vector Machine 
(SVM), and Generalized Linear Model (GLM). According to averaged results on 10 test folds (Supplementary 
Table S6) the best performing model utilizes the RF algorithm. We denoted this model IDPpi and retrained it 
on IDP datasets (Supplementary Tables S7–S11) with optimized RF for comparative evaluation on hold-out test 
sets. In the test sets one component in every protein pair was an IDP, whereas another component was randomly 
selected from sequences that were completely new to the model and bore less than 40% similarity to those used 
for training. In this way we estimated IDPpi performance on forecasting interactions even with proteins yet to 
be discovered. The predictive performance of IDPpi is compared with state-of the-art approaches M141, M242 
Figure 2. Flowchart to show the process of building data sets. Squares describe the pre-processing steps 
executed to obtain datasets for training (blue) and testing (green). Left block (white) displays the number of 
elements of PPI datasets, denoted P-sets. Right block (orange) displays the numbers of protein components to 
build protein pairs, IDPs (D-sets) and ordered proteins (O-sets).
www.nature.com/scientificreports/
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and M343 that were previously used in the aforementioned study4. Comparative testing was repeated 5 times on 
independent test sets (Supplementary Tables S12–S16) and averaged results confirmed that IDPpi outperforms 
all other methods (Table 1).
The next step was to assess how the model performs in a real-life environment where the number of negatives 
significantly surpasses the number of positives. To this end, we tested the performance of the model on test sets 
(Supplementary Tables S22, S23) in which the number of positives (N) was accompanied by the number of nega-
tives augmented several times and yet, the IDPpi model outperforms other methods. As shown in Table 2, AUCs 
and ACCs remained almost the same between the 10 N and the 100 N sets, whereas AUPRC, which is significantly 
more sensitive to absolute numbers of false positives, considerably decreased.
Mészáros and colleagues have reported previously that the interaction surfaces of IDPs represent a distinct 
employment of the principles of protein–protein recognition34. Here, we sought to demonstrate that our model 
is fine-tuned to predict interactions that involve IDPs. To this end, 5 human PPI datasets4 (Supplementary 
Tables S1–S5) were used for training of the IDPpi and test sets (Supplementary Tables S17–S21) in which the pro-
tein pairs shared only one component with the training datasets. We compared the model performances (Fig. 3) 
and confirmed its enhanced performance in predicting interactions with IDP components. As a corollary, our 
model offers significant improvements to the accuracy and coverage of human IDP interactions compared to gen-
eral proteome-wide models. It may serve as a helpful resource for understanding the core cellular functions and 
mechanistic foundations of human diseases and therefore, we offer it to the public as a convenient website: http://
www.vin.bg.ac.rs/180/tools/dispred which can test potential interactions of IDPs that are expertly curated and 
belong to the human corpus of the DisProt database. The user can select an IDP of interest from the dropdown 
Method AUC AUPRC ACC F MCC
IDPpi 0.746 ± 0.017 0.734 ± 0.020 0.670 ± 0.015 0.633 ± 0.021 0.348 ± 0.028
M1 0.688 ± 0.017 0.697 ± 0.018 0.638 ± 0.013 0.590 ± 0.022 0.285 ± 0.025
M2 0.637 ± 0.014 0.613 ± 0.012 0.593 ± 0.010 0.553 ± 0.019 0.190 ± 0.021
M3 0.627 ± 0.011 0.643 ± 0.014 0.599 ± 0.008 0.518 ± 0.013 0.211 ± 0.017
Table 1. Comparison of the prediction performances between our proposed method, IDPpi and other state-of-
the-art methods: M141, M242 and M343.
10 N 100 N
AUC AUPRC ACC AUC AUPRC ACC
IDP-PPI 0.745 0.237 0.740 0.748 0.050 0.757
M1 0.691 0.217 0.724 0.692 0.048 0.737
M2 0.645 0.140 0.648 0.646 0.025 0.657
M3 0.624 0.163 0.740 0.624 0.032 0.763
Table 2. Evaluation using a negative subsets randomly chosen from the negative set, where N is the size of the 
positive set.
Figure 3. Comparison of predictive performances through (a) ROC curves and (b) precision/recall plots. 
Performances are evaluated across 5 IDP test sets (blue) and 5 general human PPI test sets (red). In every test 
set the protein pairs shared exactly one component with the training dataset. In case of IDP test sets these 
components were IDPs.
www.nature.com/scientificreports/
5SCIENtIFIC REPORTS |  (2018) 8:10563  | DOI:10.1038/s41598-018-28815-x
menu in the left combo-box, and in the right window the user is allowed to input up to 100 prospective inter-
actors. There are no restrictions in selecting potential partners irrespective of their structural characteristics, 
evidence level or species of origin. Hence, their sequences are required to be input manually in FASTA format. 
In the query webpage we integrated cross-links to UniProt and DisProt entries that correspond to the selected 
intrinsically disordered protein. Additionally, the cross-link is provided on the NextProt dedicated page that dis-
plays information on the regions, variants and binding domains of the query protein. NextProt is a highly reliable 
manually curated knowledge platform that ensures up-to-date information on human proteins44.
We are aware that by utilizing the reference isoforms, and ignoring the effects of alternative splicing and 
post-translational modifications, protein interactome mappings fail to consider the entire human proteome com-
plexity, particularly of the IDP interactome sub-element. Even so, solving the problem of large-scale predictions 
of this IDP subset paves the way to more complex and comprehensive sequence-based PPI predictions for this 
protein class.
Illustrative example: Interactome Map of BASP1. Transcription and transcriptional regulation are 
among the most notable molecular functions that require proteins with flexible structures to underpin pre-
cisely timed and context specific processes. The brain acid-soluble protein-1 (BASP1) is a transcriptional cofac-
tor45 characterized as an intrinsically disordered structure throughout its entire sequence46. BASP1 is widely 
expressed in embryonic and adult tissues and the BASP1 gene is silenced in several tumour types47–49. The roles 
of BASP1 in health and disease are not yet well understood and we sought here to use IDPpi to predict previously 
unknown interactors and to connect this information with functional insights. Firstly, we examined the ability 
of our model to predict already known BASP1 interactors from the literature that were not used in the learning 
process. IDPpi accurately predicted 7 out of 11 known positives (Supplementary Table S24) among which are 
some of the highest-scoring IDPpi candidates (Fig. 4a): Histone Deacetylase 1 (HDAC1)50, Actin Beta (ACTB)51, 
Nucleophosmin 1 (NPM)51 and caspase 3 (CASP3)52. We further experimentally evaluated and confirmed one 
interesting novel candidate interaction between BASP1 and the progesterone receptor, PRGR (Fig. 4b). Previous 
studies have shown that BASP1 acts as a transcription cofactor for WT153, v-myc54 and estrogen receptor 
(ESR1)51. Our finding that BASP1 associates with PRGR and that interactions are predicted with several other 
DNA-binding transcription factors suggests that BASP1 is likely to be a widely deployed transcription cofactor. 
Previous studies have reported that BASP1 binds to chromatin remodelling factors (HDAC1, SMCA4)50 suggest-
ing that BASP1 acts as an interface between the DNA-bound transcription factors and proteins that modulate the 
transcription process. Indeed, the analysis presented here found that BASP1 potentially also interacts with several 
chromatin remodelling factors.
In order to understand the global functional perspective that is suggested by the projected BASP1 interactome, 
we analysed the enrichment of GO terms defined with interactors predicted by IDPpi. Further, we compared it to 
the list of enriched terms in a set of known positives and singled out correctly predicted functions and prospec-
tive BASP1 engagements. Analysed terms belong to the sub-ontology of biological processes (BP). Enrichment 
of two sets (Supplementary Tables S25, S26) was determined by BINGO55 and the terms with scores above the 
predefined cut-off are presented by the visualisation tool, Revigo56. In these scatter plots (Fig. 5), GO term nodes 
that are plotted nearer to one another are more similar in semantic space, whereas node colours showed a degree 
of enrichment. According to our findings, the predicted interactions determine that GO terms point toward pro-
cesses such as cellular component organisation, RNA metabolic processes and the cell cycle (Fig. 5, right panel). 
This aligns with terms that come out of the list of known interactors (Fig. 5, left panel). The predicted nodes 
that are grouped in the semantic space point toward specific functions that are yet to be explored for BASP1, 
such as viral processes or protein folding (Fig. 5, right panel), both known to depend on proteins with flexible 
Figure 4. (a) Case study for true positive predictions. Confirmed BASP1 interactions: HDAC1, ACTB, 
PHB, CASP3, SMCA4, ESR1, and NPM1 (blue nods) are predicted with IDPpi, whereas WT1, GELS, FLI1 
and GAP43 (grey nods) are predicted negative by the IDPpi. (b) Predicted interaction between BASP1 and 
progesterone receptor, PRGR: In vivo binding confirmation. Nuclear extracts were prepared from either MCF7 
or T47D breast cancer cells. The nuclear extracts were then subjected to immunoprecipitation with either 
control antibodies (a-IgG) or BASP1 antibodies (a-BASP1). The immunoprecipitates were subjected to SDS-
PAGE alongside 5% of input nuclear extract (I) and immunoblotted with anti-PGR antibodies. Molecular 
weight markers (kDa) are shown on the left.
www.nature.com/scientificreports/
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structures12. Note that the term “metabolic processes” that is otherwise under-represented among IDP-related 
categories of GO57, also emerged.
Finally, we used a list of predicted BASP1 interactors to point towards diseases in which BASP1 might play 
a role. To this end, Human Phenotype Ontology (HPO) which links human genes with diseases and pheno-
types58 assisted in revealing clinical abnormalities associated with genes of interest. We observed annotations for 
274 among the 1000 highest-scoring candidate BASP1 interactors in the HPO largest sub-ontology, phenotypic 
abnormality and drew a tag-cloud to emphasize over-represented concepts (Fig. 6a). According to the presented 
results, words that are most frequent, apart from neoplasm, indicate organs and tissues of diseases such as skin, 
muscle, nervous system, gastrointestinal tract and genitalia (Supplementary Table S27). We compared these find-
ings with the corpus of HPO terms associated with BASP1 in the literature, thus far (Fig. 6b). For each PubMed 
article that contained the word “BASP1” in the title and/or in abstract, we used the NCBO Annotator Web ser-
vice59 to identify mentions of disease terms from the HPO in the text. Over-represented terms linked to BASP1 
found by the Annotator (Supplementary Table S28) are displayed in Fig. 6b. One noticeable match among pre-
dicted and literature terms are skin cancer and melanoma. BASP1 has been reported to play a role in melanoma 
pathogenesis because its expression is suppressed in melanoma60, while Kaehler and colleagues demonstrated an 
association between increased BASP1 expression and improved melanoma survival61. Another correctly implied 
association connects mitochondrial disease in the literature tag-cloud and entities that express common clinical 
features of mitochondrial disease in the predicted cloud such as muscle, eye and nerve62.
Thus, we anticipate that other over-represented terms in Fig. 6a may point towards novel disease conditions 
connected with BASP1 that remain to be explored.
Concluding Remarks
IDPs are distinct due to their compositional bias which influences their binding propensities and selection of 
partners. This motivated us to develop IDPpi, a method for PPI predictions which utilizes supervised machine 
learning algorithms and compositional content together with the distribution of features associated with the pro-
motion of structural disorder along the sequence string. A subset of human IDPs that has been used for training 
is functionally important and well-explored and thus, its interactions provided a basis solid enough to develop 
a method fine-tuned to predict PPIs of this particular IDP dataset. The evaluation presented proves that IDPpi 
efficiently predicts interactions with proteins that were not used in the training process, which implies that this 
model can produce reliable predictions even on a proteome-scale. Further improvements of IDPpi will primarily 
encompass inclusion of new IDPs as prediction targets after an upgrade of the DisProt repository. In the long 
Figure 5. Enrichment analysis of GO terms related to biological processes in a set of BASP1 established (left) 
and predicted (right) interactions. Significantly enriched GO terms are plotted in the semantic space so that 
similar terms are represented close to one another. Markers are scaled and colored according to the log10 of the 
p-value for the significance of each term. Blue circles are highly significant, while red circles are less so.
www.nature.com/scientificreports/
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run, a computationally efficient and reliable approach implemented in IDPpi will serve as a solid foundation for a 
method that will reveal the full complexity of the IDP interactome by considering the effects of alternative splic-
ing and PTM on protein-binding abilities. By introducing additional layers of information that will encompass a 
significant number of isoform- and PTM-specific interactions to the current training and testing datasets we will 
be able in the future to overcome limitations imposed by present data coverage. We anticipate that IDPpi may 
contribute not only to uncovering the human interactome but also to a significantly enhanced understanding of 
the diverse roles of IDPs and therefore we offer it as a simple and convenient web tool.
Materials and Methods
Datasets. The set of human disordered proteins and human proteins with disordered regions sequences were 
retrieved from the DisProt24 and UniProt/Swiss-Prot. The PPI dataset was obtained by searching the content of 
the HIPPIE v2.025 for interaction partners of IDPs. Given that the HIPPIE database confers interacting partners 
only through gene name identifiers the isoform involved in the interaction is not known and therefore the sets 
were constructed from reference isoforms. As a result, the tau protein and calcyclin-binding protein that are 
present in DisProt only as alternative isoforms were not considered in this study. This list was further refined by 
the following steps: (1) proteins containing less than 50 amino acid were removed to filter out small proteins and 
protein fragments. The PPI dataset was obtained by searching the content of the HIPPIE v2.025 for interaction 
partners of IDPs. The dataset of interaction partners was cleared of sequences that correspond to protein names 
containing the words ‘putative’, ‘potential’ or ‘uncharacterized’. The non-redundant subset of interaction partners 
was generated at the sequence identity level of 40% by clustering analysis using the CD-Hit31. Negative PPI data 
were formed from all human protein pairs containing exactly one IDP component. No negative PPI was listed as 
a positive in the full Hippie database.
Protein interaction features. Sequences and protein pairs were represented by features derived from: (i) 
pseudo amino acid composition (PAAC)40 and (ii) dipeptide composition. PAAC combines conventional amino 
acid composition and sequence order correlates of various amino acid features. Amino acid scales that we utilized 
to encode sequences are provided in the Supplementary Table S29. In this way PAAC vectorizes a protein into a 
20 + λ-feature vector, in which the first 20 components are the conventional amino acid composition and the rest 
depend on the maximum value correlation tier, λ. In the current study, the λ value was set to 50 which established 
the minimum sequence length as 51. In this way sequences were represented by 70 PAAC components.
Sequences were presented with dipeptide composition which takes every two consecutive amino acids as a 
single unit and counts the frequency of all of the dipeptide patterns. It then represents each sequence with a fixed 
length vector of 400.
Figure 6. Tag-clouds representing disease terms (a) over-represented among 1000 top-scoring IDPI predicted 
interactors and (b) co-mentioned with BASP1 in the literature. The tag-cloud displays more frequently 
appearing terms using larger font sizes. Neoplasm is the dominant term in both presentations, whereas 
melanoma and skin are related terms.
www.nature.com/scientificreports/
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Protein interactions were vectorized by concatenation of the vector representations for both proteins from the 
interaction pair. Therefore, the total number of dimensions of vector representation for single protein interaction 
is 940.
Classification algorithms. For generating the classification model we used (i) tree based classifiers: ran-
dom forests method63 and gradient boosting machine64; (ii) linear classifier, generalized linear model65 and 
(iii) kernel based support vector machine66. The process of modelling was carried out using RStudio integrated 
development environment67, while the software was implemented using R and JAVA programming languages. 
In order to determine whether the classifiers were able to learn general concepts or failed to generalize well on 
unseen data (overfit), we performed a ten-fold cross-validation over general protein datasets (Supplementary 
Tables S1–S5) provided in the study of Park and Marcotte4. These results were used to select the best performing 
machine learning algorithm. The best performing model was further retrained on IDP datasets (Supplementary 
Tables S7–S11) with optimized RF for further evaluation on hold-out test sets (Supplementary Tables S12–S16) 
that corresponded to the C2 class as described in4.
As a performance metrics we used the area under receiver operating characteristic curve (AUC) or 
recall-fallout plot, area under precision-recall plots (AUPRC), and accuracy (ACC), F score, precision, recall 
(sensitivity or true positive rate), fall-out (false positive rate) and Matthews correlation coefficient (MCC), calcu-
lated with the 0.5 threshold value.
Cartesian grid search and random search68 were used for hyperparameter optimization for each of the 
machine learning methods. For Random Forest following hyperparameters were tuned: number of trees, maxi-
mum tree depth, minimum number of observations for a leaf, histogram type, number of bins for the histogram, 
row sampling rate and number of columns to randomly select at each level; for Gradient Boosting Machine: num-
ber of trees, maximum tree depth, minimum number of observations for a leaf, histogram type, number of bins 
for the histogram, learning rate, row sampling rate and loss function; for Generalized Linear Model: model type, 
solver, penalized model, regularization penalties, beta epsilon value and maximum number of active predictors; 
for Support Vector Machine: C and gamma parameters and kernel function.
State of the art methods for comparison. The method denoted M1 was developed by Martin et al.41 
and relies on a signature product that is implemented within a SVM classifier as a kernel function. Next, M2, the 
method developed by Guo and coworkers42 utilizes sequences represented by a feature vector based on autocor-
relation values of 7 physicochemical scales. The feature vectors are then concatenated for a protein pair and clas-
sified by an SVM. Finally, M3 method43 represented a protein sequence vectorized by a tri-peptide composition.
Experimental testing. MCF7 and T47D cells were maintained as described in51. Immunoprecipitation was 
performed as described in53. PGR antibody was from Santa Cruz Biotechnology (Sc-538). BASP1 antibodies were 
described in Carpenter et al.53.
Gene ontology and enrichment analysis. Biological process (BP) gene ontology (GO) term 
over-representation was calculated using BiNGO v3.0.3in Cytoscape v3.4.0, employing the hypergeometric test 
and applying a significance cutoff of FDR-adjusted P-value ≤ 0.05. The 17,531 human genes were used as the ref-
erence set, and the GO ontology and annotation files used were downloaded on Oct. 25, 2017. The output from 
BiNGO55 was imported into ReviGO56 to depict the list of significant GO terms by selecting representative subsets 
using a simple clustering algorithm that relies on measures of semantic similarity between terms.
Annotating text using terms from the Human Phenotype Ontology (HPO). For each PubMed 
article which contains the word BASP1 in the title and/or abstract, we used the NCBO Annotator Web-service59 
to identify mentions of disease terms from the HPO58 in the text as described in69. We configured the service to 
find the whole-word, direct terms matches for term labels and synonyms from the HPO. The HPO is indicated 
by the BioPortal version 5.3.1. The obtained word lists were clarified from non-informative terms: abnormal-
ity, disease, disorder, system, morphology, physiology, function and involving. Term lists were submitted to the 
online cloud generating software Wordle (http://www.wordle.net) and visualized using the “Horizontal” layout. 
Non-specific terms (such as Abnormality, Disease) are not used in tag-cloud representations.
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